The Alive Study: A Longitudinal Study of HIV-1 Infection in Intravenous Drug Users: Description of Methods
暂无分享,去创建一个
A Munoz | J. Margolick | D. Vlahov | J. Anthony | B. Polk | A. Muñoz | D. Celentano | K. Nelson | B F Polk | D D Celentano | D Vlahov | J C Anthony | K E Nelson | J Margolick | L. Solomon | L Solomon | K. Nelson | B. Polk | David D. Celentano | James C. Anthony
[1] Ccfp,et al. The Vancouver Lymphadenopathy-AIDS Study: 4. Effects of exposure factors, cofactors and HTLV-III seropositivity on number of helper T cells. , 1985, Canadian Medical Association journal.
[2] Joan S. Chmiel,et al. Acquired immunodeficiency syndrome (AIDS)-free time after human immunodeficiency virus type 1 (HIV-1) seroconversion in homosexual men. Multicenter AIDS Cohort Study Group. , 1989, American journal of epidemiology.
[3] S Magura,et al. Determinants of needle sharing among intravenous drug users. , 1989, American journal of public health.
[4] R. Hoffman,et al. Simple and rapid measurement of human T lymphocytes and their subclasses in peripheral blood. , 1980, Proceedings of the National Academy of Sciences of the United States of America.
[5] P. Biernacki,et al. TARGETED SAMPLING: OPTIONS FOR THE STUDY OF HIDDEN POPULATIONS , 1989 .
[6] S. Zolla-Pazner,et al. Kaposi's sarcoma among four different AIDS risk groups. , 1984, The New England journal of medicine.
[7] J. Phair,et al. The Multicenter AIDS Cohort Study: rationale, organization, and selected characteristics of the participants. , 1987, American journal of epidemiology.
[8] J. Phair,et al. Predictors of decline in CD4 lymphocytes in a cohort of homosexual men infected with human immunodeficiency virus. , 1988, Journal of acquired immune deficiency syndromes.
[9] W. El-Sadr,et al. Risk factors for infection with human immunodeficiency virus among intravenous drug abusers in New York City. , 1987, AIDS.
[10] D. Shine,et al. Intravenous drug abusers and the acquired immunodeficiency syndrome (AIDS). Demographic, drug use, and needle-sharing patterns. , 1985, Archives of internal medicine.
[11] S. Friedman,et al. Prevalence of antibody to lymphadenopathy-associated virus among drug-detoxification patients in New York. , 1984, The New England journal of medicine.
[12] J. Garber,et al. Development of AIDS, HIV seroconversion, and potential co-factors for T4 cell loss in a cohort of intravenous drug users. , 1987, AIDS.
[13] W. El-Sadr,et al. The epidemic of acquired immunodeficiency syndrome (AIDS) and suggestions for its control in drug abusers. , 1984, Journal of substance abuse treatment.
[14] S. Zolla-Pazner,et al. Nonrandom development of immunologic abnormalities after infection with human immunodeficiency virus: implications for immunologic classification of the disease. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[15] B. Truman,et al. Survival with the acquired immunodeficiency syndrome. Experience with 5833 cases in New York City. , 1987, The New England journal of medicine.
[16] M. Chamberland,et al. Heterosexually acquired infection with human immunodeficiency virus (HIV). A view from the III International Conference on AIDS. , 1987, Annals of internal medicine.
[17] J. Levy,et al. Sexual practices and risk of infection by the human immunodeficiency virus. The San Francisco Men's Health Study. , 1987, JAMA.
[18] J. Jaffe,et al. Geographic distribution of human immunodeficiency virus markers in parenteral drug abusers. , 1988, American journal of public health.
[19] R. Chaisson,et al. Human immunodeficiency virus infection in heterosexual intravenous drug users in San Francisco. , 1987, American journal of public health.